Key result
Female sex is linked to ~38% lower mortality or heart transplant in idiopathic DCM.
Why the study?
The study evaluated possible clinical, instrumental, natural history, and prognostic divergences between women and men with idiopathic dilated cardiomyopathy.
Does female gender improve long-term prognosis in patients with idiopathic dilated cardiomyopathy compared to male gender?
Cohort (n=803)
No
Does female gender improve long-term prognosis in patients with idiopathic dilated cardiomyopathy compared to male gender?
Absolute Event Rate: 20% vs 32%
p-value: p=0.001
Women with idiopathic dilated cardiomyopathy demonstrate a significantly better long-term survival and lower rate of heart transplantation compared to men, despite presenting with more advanced baseline disease characteristics.
Sex differences in IDCM prognosis warrant cautious risk assessment; leaves open need for prospective validation before guiding therapy.
Objective. To evaluated possible clinical and instrumental, natural history and prognostic divergences in women and men with idiopathic dilated cardiomyopathy (IDCM). Patients and Methods. From 1988 to 2012, we evaluated 803 consecutive patients with IDCM recorded in the Heart Muscle Disease Registry of Trieste (Italy). All patients had serial follow-up evaluations at 6, 12, and 24 months, and subsequently every two years, or more frequently if clinically indicated. Results. Two hundred and twenty-seven patients (28%) were female. At first evaluation women were significantly older (48 vs. 45 years old, p = 0.008); presented more frequently left bundle branch block at ECG (38% vs. 28%, p = 0.01), smaller left ventricular end-diastolic indexed volume at echocardiography (85 vs. 93 ml/m2, p <0.002) and more frequently moderate to severe mitral regurgitation at Doppler (43% vs. 33%, p = 0.015). No differences in NYHA class, medical treatment and device implantation rates were found. During a median of 108 months follow-up, women showed a significantly lower ten-year total mortality/heart transplantation (20% vs. 32% respectively, p = 0.001) and cardiovascular mortality rates (9% vs. 15%, p = 0.024) despite a less marked clinical and echocardiographic improvement. Conclusions. In our population of patients with IDCM, women showed a better long-term prognosis notwithstanding a presentation with a more advanced disease and a lower clinical-instrumental improvement on optimal medical therapy compared to men.
No takes yet. Share an insight, caveat, or question.
Serdoz et al. (2022) conducted a cohort in Idiopathic Dilated Cardiomyopathy (n=803). Female sex vs. Male sex was evaluated on Total mortality or heart transplantation (p=0.001). Female sex was associated with a significantly lower rate of total mortality or heart transplantation compared to male sex (20% vs. 32%, p=0.001) in patients with idiopathic dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: